Acute chest syndrome
| Acute chest syndrome | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Chest pain, cough, fever, shortness of breath |
| Complications | Respiratory failure, pulmonary hypertension |
| Onset | Sudden |
| Duration | Varies |
| Types | N/A |
| Causes | Sickle cell disease, infection, fat embolism |
| Risks | Sickle cell anemia, sickle cell trait |
| Diagnosis | Chest X-ray, blood tests, pulse oximetry |
| Differential diagnosis | Pneumonia, pulmonary embolism, myocardial infarction |
| Prevention | N/A |
| Treatment | Oxygen therapy, antibiotics, blood transfusion, pain management |
| Medication | Antibiotics, analgesics |
| Prognosis | Variable, can be life-threatening |
| Frequency | Common in individuals with sickle cell disease |
| Deaths | N/A |
A complication of sickle cell disease
Acute chest syndrome (ACS) is a serious complication of sickle cell disease (SCD) characterized by chest pain, fever, and pulmonary infiltrates on a chest X-ray. It is a leading cause of morbidity and mortality in patients with sickle cell disease.
Pathophysiology[edit]
Acute chest syndrome is primarily caused by the sickling of red blood cells in the pulmonary vasculature, leading to vaso-occlusion and subsequent ischemia and infarction of lung tissue. This process can be triggered by various factors, including infection, fat embolism, and pulmonary embolism. The resulting inflammation and hypoxia further exacerbate the sickling process, creating a vicious cycle.
Clinical Presentation[edit]
Patients with acute chest syndrome typically present with sudden onset of chest pain, dyspnea, and fever. Other symptoms may include cough, tachypnea, and hypoxemia. The condition can rapidly progress to acute respiratory distress syndrome (ARDS) if not promptly treated.
Diagnosis[edit]
The diagnosis of acute chest syndrome is primarily clinical, supported by imaging and laboratory findings. A chest X-ray typically shows new pulmonary infiltrates, which may be bilateral or unilateral. Laboratory tests often reveal leukocytosis, anemia, and elevated inflammatory markers. Pulse oximetry may show decreased oxygen saturation.
Management[edit]
The management of acute chest syndrome involves supportive care and specific treatments to address the underlying causes. Key components of management include:
- Oxygen therapy to maintain adequate oxygenation.
- Intravenous fluids to prevent dehydration and reduce sickling.
- Pain management with analgesics to control chest pain.
- Antibiotics if an infectious cause is suspected.
- Blood transfusion to reduce the proportion of sickled cells and improve oxygen delivery.
- Bronchodilators and incentive spirometry to improve lung function.
Prognosis[edit]
The prognosis of acute chest syndrome varies depending on the severity of the episode and the timeliness of treatment. Early recognition and aggressive management are crucial to prevent complications such as respiratory failure and multi-organ failure. Recurrent episodes of acute chest syndrome can lead to chronic lung disease and decreased life expectancy in patients with sickle cell disease.
Prevention[edit]
Preventive strategies for acute chest syndrome include regular vaccination against pneumococcus and influenza, hydroxyurea therapy to reduce sickling episodes, and chronic transfusion therapy in high-risk patients. Patient education on recognizing early symptoms and seeking prompt medical attention is also essential.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian